Compare OLB & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLB | PMCB |
|---|---|---|
| Founded | 1993 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7M | 8.3M |
| IPO Year | 2019 | 2001 |
| Metric | OLB | PMCB |
|---|---|---|
| Price | $0.43 | $0.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 351.4K | 147.8K |
| Earning Date | 05-14-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 71.48 | ★ 277.22 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,676,907.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.52 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.31 | $0.63 |
| 52 Week High | $2.50 | $1.51 |
| Indicator | OLB | PMCB |
|---|---|---|
| Relative Strength Index (RSI) | 37.90 | 46.73 |
| Support Level | $0.31 | $0.65 |
| Resistance Level | $0.58 | $0.80 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 24.77 | 29.10 |
The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise. It focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. Along with its subsidiaries, the company offers a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses, whether online or at a brick-and-mortar location, payment processing solutions, payment gateway, virtual terminal with proprietary business management tools, and crowdfunding solutions. The company has two business segments; Fintech Services which generates key revenue, and the Bitcoin Mining business segment.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.